This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Calibr at Scripps Research is celebrating a major milestone, a decade of discovery. Take a look at the past 10 years of scientific innovation, and see what the next 10 years have in store.
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines, celebrating its 10-year anniversary in 2022. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science.
Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs.
When it comes to knowing yourself, your own perception of your personality doesn’t necessarily align with that of people around you. But which is more accurate? And can discovering your true nature lead to a better life?
The International Liquid Mirror Telescope, perched high in the Himalayas, has finally started making observations. If it succeeds, we could one day put a much larger liquid telescope on the moon
Space agencies are preparing to send the next generation of astronauts to the moon and beyond. Here’s how the next crews will be different from the last ones.
The successful use of engineered white blood cells (cells that are removed from the human body, modified with receptors that allow them to recognize cancer cells, and then returned to the body) to fight and eliminate tumor cells has frequently been called revolutionary and has even allowed researchers the rare opportunity to refer to a cure for certain cancers.